| 臺大學術典藏 |
2021-05-06T01:53:10Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang C.-T.; YEE-CHUN CHEN; Lin S.-F.; Shau W.-Y.; Liu C.-J.; Sheng W.-H.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-06-24T07:16:08Z |
Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ?3 Months to <18 Years with Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial
|
Bradley J.S.;Roilides E.;Broadhurst H.;Cheng K.;Li-Min Huang;Mascasullo V.;Newell P.;Stone G.G.;Tawadrous M.;Wajsbrot D.;Yates K.;Gardner A.; Bradley J.S.; Roilides E.; Broadhurst H.; Cheng K.; LI-MIN HUANG; Mascasullo V.; Newell P.; Stone G.G.; Tawadrous M.; Wajsbrot D.; Yates K.; Gardner A. |
| 臺大學術典藏 |
2022-03-28T02:45:56Z |
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
|
Schoser B.; Roberts M.; Byrne B.J.; Sitaraman S.; Jiang H.; Lafor?t P.; Toscano A.; Castelli J.; D?az-Manera J.; Goldman M.; van der Ploeg A.T.; Bratkovic D.; Kuchipudi S.; Mozaffar T.; Kishnani P.S.; Sebok A.; Pestronk A.; Dominovic-Kovacevic A.; Khan A.; Koritnik B.; Tard C.; Lindberg C.; Quinn C.; Eldridge C.; Bodkin C.; Reyes-Leiva D.; Hughes D.; Stefanescu E.; SALORT-CAMPANA E.; Butler E.; Bouhour F.; Kim G.; Konstantinos Papadimas G.; Parenti G.; Bartosik-Psujek H.; Kushlaf H.; Akihiro H.; Lau H.; Pedro H.; Andersen H.; Amartino H.; Shiraishi H.; Kobayashi H.; Tarnev I.; Vengoechea J.; Avelar J.; Shin J.-H.; Cauci J.; Alonso-P?rez J.; Janszky J.; Berthy J.; Cornelia K.; Gutschmidt K.; Claeys K.; Judit Molnar M.; Wencel M.; Tarnopolsky M.; Dimachkie M.; Tchan M.; Freimer M.; Longo N.; Vidal-Fernandez N.; Musumeci O.; Goker-Alpan O.; Deegan P.; Clemens P.R.; Roxburgh R.; Henderson R.; Hopkin R.; Sacconi S.; Fecarotta S.; Attarian S.; Wenninger S.; Dearmey S.; Hiwot T.; Burrow T.; Ruck T.; Sawada T.; Laszlo V.; L?scher W.; YIN-HSIU CHIEN; PROPEL Study Group |
| 國立臺灣大學 |
2012 |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai, Chung-Chih; Sheng, Wang-Huei; Wang, Jann-Tay; Liao, Chun-Hsin; Ho, Mao-Wang; Chen, Chwen-Je; Chen, Der-Li; Chou, Ming-Uen; Lee, Chien-Ming; Lin, Yee-Chun; Pong, Ming-Ye; Chang, Shan-Chwen; 張上淳 |
| 臺大學術典藏 |
2021-02-26T02:00:01Z |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai C.-C.; WANG-HUEI SHENG; Wang J.-T.; Liao C.-H.; Ho M.-W.; Chen C.-J.; Chen D.-L.; Chou M.-U.; Lee C.-M.; Lin Y.-C.; Pong M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2022-05-13T08:04:50Z |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai C.-C.; Sheng W.-H.; JANN-TAY WANG; Liao C.-H.; Ho M.-W.; Chen C.-J.; Chen D.-L.; Chou M.-U.; Lee C.-M.; Lin Y.-C.; Pong M.-Y.; Chang S.-C. |
| 國立成功大學 |
2019 |
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
|
Wei, L.;Kumada, H.;Perumalswami, Perumalswami P.V.;Tanwandee, Tanwandee T.;Cheng, W.;Heo, J.;Cheng, P.-N.;Hwang, P.;Mu, S.M.;Zhao, X.M.;Asante-Appiah, E.;Caro, L.;Hanna, G.J.;Robertson, M.N.;Haber, B.A.;Talwani, R. |
| 臺大學術典藏 |
2022-05-14T23:35:54Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
NI-CHUNG LEE; YIN-HSIU CHIEN; Wang, Chung Hsing; Wong, Siew Lee; STEVEN SHINN-FORNG PENG; Tsai, Fuu Jen; WUH-LIANG HWU |
| 臺大學術典藏 |
2022-05-17T06:03:52Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
NI-CHUNG LEE; YIN-HSIU CHIEN; Wang, Chung Hsing; Wong, Siew Lee; STEVEN SHINN-FORNG PENG; Tsai, Fuu Jen; WUH-LIANG HWU |
| 臺大學術典藏 |
2022-09-06T02:56:09Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
Lee N.-C.; YIN-HSIU CHIEN; Wang C.-H.; Wong S.-L.; Peng S.S.-F.; Tsai F.-J.; Hwu W.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:39Z |
Safety and efficacy of EUS-guided ethanol ablation for treating small solid pancreatic Neoplasm
|
Paik W.H.; Seo D.W.; Dhir V.; HSIU-PO WANG |
| 國立臺灣大學 |
2008 |
Safety and Efficacy of Exenatide in Patients of Asian Descent with Type 2 Diabetes Taking Metformin or Metformin with a Sulfonylurea
|
莊立民; BRODOWS ROBERT; MOHAN VISHWANATHAN; CHUANG, LEE-MING; YOON KUN HO; GAO YAN |
| 臺大學術典藏 |
2018-09-10T18:03:26Z |
Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
|
Wu, M.-Y. ; Chen, Y.-C. ; Lin, C.-H. ; Wu, Y.-C. ; Tu, Y.-K. ; Tarng, D.-C.; YU-KANG TU |
| 臺大學術典藏 |
2022-05-10T08:10:10Z |
Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
|
Wu M.-Y.; Chen Y.-C.; Lin C.-H.; Wu Y.-C.; YU-KANG TU; Tarng D.-C. |
| 國立臺灣大學 |
2013 |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai, Chung-Chih; Sheng, Wang-Huei; Wang, Jann-Tay; Cheng, Aristine; Chuang, Yu-Chung; Chen, Yee-Chun; Chang, Shan-Chwen; 張上淳; 陳宜君; 盛望徽; 王振泰; 莊祐中 |
| 臺大學術典藏 |
2018-09-10T09:46:34Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai, Chung-Chih;Sheng, Wang-Huei;Wang, Jann-Tay;Cheng, Aristine;Chuang, Yu-Chung;Chen, Yee-Chun;Chang, Shan-Chwen; Lai, C.-C. and Sheng, W.-H. and Wang, J.-T. and Cheng, A. and Chuang, Y.-C. and Chen, Y.-C. and Chang, S.-C.; 張上淳 ;陳宜君 ;盛望徽 ;王振泰 ;莊祐中; WANG-HUEI SHENG; Lai, Chung-Chih; Sheng, Wang-Huei; ARISTINE CHENG; Wang, Jann-Tay; SHAN-CHWEN CHANG; YEE-CHUN CHEN; Cheng, Aristine; Chuang, Yu-Chung; YU-CHUNG CHUANG; Chen, Yee-Chun; JANN-TAY WANG; Chang, Shan-Chwen |
| 臺大學術典藏 |
2020-09-29T01:47:47Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Sheng W.-H.; Lai C.-C.; Lai C.-C.;Sheng W.-H.;Wang J.-T.;Cheng A.;Chuang Y.-C.;Yee-Chun Chen;Chang S.-C.; Chang S.-C.; Chuang Y.-C.; YEE-CHUN CHEN; Cheng A.; Wang J.-T. |
| 臺大學術典藏 |
2021-02-26T01:59:57Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; WANG-HUEI SHENG; Wang J.-T.; Cheng A.; Chuang Y.-C.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:52:16Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; Sheng W.-H.; Wang J.-T.; Cheng A.; Chuang Y.-C.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:25Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; Sheng W.-H.; Wang J.-T.; ARISTINE CHENG; Chuang Y.-C.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2013 |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.;Sheng W.-H.;Wang J.-T.;Cheng A.;Chuang Y.-C.;Chen Y.-C.;Shan-Chwen Chang; Lai C.-C.; Sheng W.-H.; Wang J.-T.; Cheng A.; Chuang Y.-C.; Chen Y.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2022-05-13T08:04:45Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; Sheng W.-H.; JANN-TAY WANG; Cheng A.; Chuang Y.-C.; Chen Y.-C.; Chang S.-C. |
| 國立臺灣大學 |
2009-12 |
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants
|
Phua, KB; Lim, FS; Lau, YL; Nelson, EA; Huang, LM; Quak, SH; Lee, BW; Teoh, YL; Tang, H; Boudville, I; Oostvogels, LC; Suryakiran, PV; Smolenov, IV; Han, HH; Bock, HL |
| 國立臺灣大學 |
2009 |
Safety and Efficacy of Human Rotavirus Vaccine during the First 2 Years of Life in Asian Infants: Randomised, Double-Blind, Controlled Study
|
黃立民; HUANG, LI-MIN |
| 臺大學術典藏 |
2021-06-24T07:16:59Z |
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
|
Phua K.B.; Lim F.S.; Lau Y.L.; Nelson E.A.S.; LI-MIN HUANG; Quak S.H.; Lee B.W.; Teoh Y.L.; Tang H.; Boudville I.; Oostvogels L.C.; Suryakiran P.V.; Smolenov I.V.; Han H.H.; Bock H.L. |
